Research presented recently at the ECTRIMS Congress 2025 highlights the patient perspective on menopause and MS.
Learn about workplace accommodations for MS, your rights under the ADA, and practical tips for managing multiple sclerosis at ...
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
For columnist Leigh Anne Nelson, the benefits of owning dogs include a constant source of comfort and motivation to stay ...
The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...
With FDA-requested toxicology reports in hand, Quantum is preparing to seek clearance for stating the first trial of Lucid-MS ...
Routine is important, says columnist Ben Hofmeister, but when MS changes your abilities, sometimes you must adapt your ways.
Zenas Biopharma has acquired global rights to develop BTK inhibitor orelabrutinib to treat progressive forms of multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results